IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,186,919 | -51.9% | 260,868 | -25.6% | 0.00% | -50.0% |
| Q2 2023 | $2,469,818 | +41.0% | 350,821 | +22.4% | 0.00% | +33.3% |
| Q1 2023 | $1,751,714 | -7.1% | 286,691 | -2.8% | 0.00% | -25.0% |
| Q4 2022 | $1,885,195 | -31.2% | 295,022 | +3.2% | 0.00% | -33.3% |
| Q3 2022 | $2,740,000 | -21.4% | 285,981 | -9.5% | 0.01% | -25.0% |
| Q2 2022 | $3,487,000 | -23.9% | 315,913 | +14.9% | 0.01% | -11.1% |
| Q1 2022 | $4,580,000 | -10.1% | 275,012 | +3.1% | 0.01% | -10.0% |
| Q4 2021 | $5,094,000 | -7.2% | 266,771 | +19.9% | 0.01% | -16.7% |
| Q3 2021 | $5,489,000 | -9.0% | 222,404 | -4.0% | 0.01% | -7.7% |
| Q2 2021 | $6,032,000 | -14.1% | 231,623 | +4.6% | 0.01% | -27.8% |
| Q1 2021 | $7,023,000 | -52.5% | 221,442 | -30.5% | 0.02% | -52.6% |
| Q4 2020 | $14,779,000 | +31.9% | 318,527 | -6.4% | 0.04% | +18.8% |
| Q3 2020 | $11,207,000 | +12.0% | 340,374 | -6.6% | 0.03% | +3.2% |
| Q2 2020 | $10,008,000 | +18.9% | 364,564 | +29.7% | 0.03% | 0.0% |
| Q1 2020 | $8,414,000 | +168.3% | 281,125 | +148.2% | 0.03% | +244.4% |
| Q4 2019 | $3,136,000 | +226.7% | 113,264 | +114.8% | 0.01% | +350.0% |
| Q3 2019 | $960,000 | -40.0% | 52,727 | -19.1% | 0.00% | -60.0% |
| Q2 2019 | $1,599,000 | +586.3% | 65,197 | +166.7% | 0.01% | +400.0% |
| Q1 2019 | $233,000 | – | 24,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |